Siculella Luisa, Giannotti Laura, Di Chiara Stanca Benedetta, Calcagnile Matteo, Rochira Alessio, Stanca Eleonora, Alifano Pietro, Damiano Fabrizio
Laboratory of Molecular Biology, Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy.
Laboratory of Microbiology, Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy.
Int J Mol Sci. 2021 Apr 7;22(8):3804. doi: 10.3390/ijms22083804.
Reactive intermediate deaminase (Rid) proteins are enzymes conserved in all domains of life. UK114, a mammalian member of RidA subfamily, has been firstly identified as a component of liver perchloric acid-soluble proteins (L-PSP). Although still poorly defined, several functions have been attributed to the mammalian protein UK114/RIDA, including the reactive intermediate deamination activity. The expression of UK114/RIDA has been observed in some tumors, arousing interest in this protein as an evaluable tumor marker. However, other studies reported a negative correlation between UK114/RIDA expression, tumor differentiation degree and cell proliferation. This work addressed the question of UK114/RIDA expression in human non-tumor HEK293 cell lines and in some human tumor cell lines. Here we reported that human RIDA (hRIDA) was expressed in all the analyzed cell line and subjected to lysine (K-)succinylation. In HEK293, hRIDA K-succinylation was negatively correlated to the cell proliferation rate and was under the control of SIRT5. Moreover, K-succinylation clearly altered hRIDA quantification by immunoblotting, explaining, at least in part, some discrepancies about RIDA expression reported in previous studies. We found that hRIDA was able to deaminate reactive enamine-imine intermediates and that K-succinylation drastically reduced deaminase activity. As predicted by in silico analysis, the observed reduction of deaminase activity has been related to the drastic alterations of hRIDA structure inferred by K-succinylation. The role of hRIDA and the importance of its K-succinylation in cell metabolism, especially in cancer biology, have been discussed.
反应性中间物脱氨酶(Rid)蛋白是在生命的所有领域中都保守的酶。UK114是RidA亚家族的哺乳动物成员,最初被鉴定为肝脏高氯酸可溶性蛋白(L-PSP)的一个组分。尽管其功能仍未完全明确,但哺乳动物蛋白UK114/RIDA已被赋予多种功能,包括反应性中间物脱氨活性。在一些肿瘤中已观察到UK114/RIDA的表达,这引起了人们对该蛋白作为一种可评估的肿瘤标志物的兴趣。然而,其他研究报道UK114/RIDA表达与肿瘤分化程度和细胞增殖之间呈负相关。这项工作探讨了UK114/RIDA在人非肿瘤HEK293细胞系和一些人肿瘤细胞系中的表达问题。在此我们报道,人RIDA(hRIDA)在所有分析的细胞系中均有表达,并发生了赖氨酸(K-)琥珀酰化。在HEK293细胞中,hRIDA的K-琥珀酰化与细胞增殖速率呈负相关,且受SIRT5的调控。此外,K-琥珀酰化明显改变了通过免疫印迹法对hRIDA的定量,这至少部分解释了先前研究中报道的关于RIDA表达的一些差异。我们发现hRIDA能够使反应性烯胺-亚胺中间物脱氨,并且K-琥珀酰化极大地降低了脱氨酶活性。正如计算机分析所预测的,观察到的脱氨酶活性降低与K-琥珀酰化推断的hRIDA结构的剧烈改变有关。文中讨论了hRIDA的作用及其K-琥珀酰化在细胞代谢尤其是癌症生物学中的重要性。